{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:10:40Z","timestamp":1788826240814,"version":"build-2803163510"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11358-8","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T13:45:41Z","timestamp":1754660741000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Antimicrobial resistance of uropathogens in diabetic patients"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1739-6948","authenticated-orcid":false,"given":"Anas H.","family":"Abu-Humaidan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1079-5633","authenticated-orcid":false,"given":"Yazeed Y.","family":"Alajlouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3783-2284","authenticated-orcid":false,"given":"Amin Y.","family":"Alajlouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0442-0578","authenticated-orcid":false,"given":"Omar F.","family":"Hamdan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6014-3712","authenticated-orcid":false,"given":"Batool L.","family":"Basyouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2887-7150","authenticated-orcid":false,"given":"Ola F.","family":"Qasem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7009-7853","authenticated-orcid":false,"given":"Abdallah A.","family":"Riyalat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8739-3102","authenticated-orcid":false,"given":"Ruba I.","family":"Hiasat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3409-4824","authenticated-orcid":false,"given":"Anmar H.","family":"Magharbeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3659-8203","authenticated-orcid":false,"given":"Nader","family":"Alaridah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,26]]},"reference":[{"issue":"2","key":"11358_CR1","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1080\/00325481.2017.1246055","volume":"129","author":"MS Bader","year":"2017","unstructured":"Bader MS, Loeb M, Brooks AA. An update on the management of urinary tract infections in the era of antimicrobial resistance. Postgrad Med. 2017;129(2):242\u201358.","journal-title":"Postgrad Med"},{"issue":"1","key":"11358_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/QCO.0000000000000228","volume":"29","author":"Z Tandogdu","year":"2016","unstructured":"Tandogdu Z, Wagenlehner FM. Global epidemiology of urinary tract infections. Curr Opin Infect Dis. 2016;29(1):73\u20139.","journal-title":"Curr Opin Infect Dis"},{"issue":"5","key":"11358_CR3","doi-asserted-by":"publisher","first-page":"e103","DOI":"10.1093\/cid\/ciq257","volume":"52","author":"K Gupta","year":"2011","unstructured":"Gupta K, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the infectious diseases society of America and the European society for microbiology and infectious diseases. Clin Infect Dis. 2011;52(5):e103\u201320.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"11358_CR4","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1517\/13543784.2016.1161024","volume":"25","author":"MM Zacch\u00e8","year":"2016","unstructured":"Zacch\u00e8 MM, Giarenis I. Therapies in early development for the treatment of urinary tract inflammation. Expert Opin Investig Drugs. 2016;25(5):531\u201340.","journal-title":"Expert Opin Investig Drugs"},{"issue":"10","key":"11358_CR5","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41585-020-0362-4","volume":"17","author":"FME Wagenlehner","year":"2020","unstructured":"Wagenlehner FME, et al. Epidemiology, definition and treatment of complicated urinary tract infections. Nat Reviews Urol. 2020;17(10):586\u2013600.","journal-title":"Nat Reviews Urol"},{"key":"11358_CR6","doi-asserted-by":"publisher","first-page":"3588297","DOI":"10.1155\/2022\/3588297","volume":"2022","author":"S Paudel","year":"2022","unstructured":"Paudel S, et al. Systematic review of literature examining bacterial urinary tract infections in diabetes. J Diabetes Res. 2022;2022:3588297.","journal-title":"J Diabetes Res"},{"key":"11358_CR7","first-page":"129","volume":"8","author":"O Nitzan","year":"2015","unstructured":"Nitzan O, et al. Urinary tract infections in patients with type 2 diabetes mellitus: review of prevalence, diagnosis, and management. Diabetes Metab Syndr Obes. 2015;8:129\u201336.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"1","key":"11358_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13756-019-0675-3","volume":"9","author":"DM Zhu","year":"2020","unstructured":"Zhu DM, et al. Risk factors for quinolone-resistant Escherichia coli infection: a systematic review and meta-analysis. Antimicrob Resist Infect Control. 2020;9(1):11.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"4","key":"11358_CR9","doi-asserted-by":"publisher","first-page":"546","DOI":"10.4103\/IJPM.IJPM_261_16","volume":"60","author":"A Chakraborty","year":"2017","unstructured":"Chakraborty A, et al. Is diabetes mellitus an important risk factor for the antibiotic resistance in extraintestinal pathogenic Escherichia coli? Indian J Pathol Microbiol. 2017;60(4):546\u20139.","journal-title":"Indian J Pathol Microbiol"},{"issue":"9","key":"11358_CR10","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1111\/j.1464-5491.2004.01169.x","volume":"21","author":"R Meiland","year":"2004","unstructured":"Meiland R, et al. Diabetes mellitus in itself is not a risk factor for antibiotic resistance in Escherichia coli isolated from patients with bacteriuria. Diabet Med. 2004;21(9):1032\u20134.","journal-title":"Diabet Med"},{"issue":"1","key":"11358_CR11","doi-asserted-by":"publisher","first-page":"29","DOI":"10.4066\/AMJ.2014.1906","volume":"7","author":"SM Aswani","year":"2014","unstructured":"Aswani SM, et al. Clinical profile of urinary tract infections in diabetics and non-diabetics. Australas Med J. 2014;7(1):29\u201334.","journal-title":"Australas Med J"},{"issue":"1","key":"11358_CR12","doi-asserted-by":"publisher","first-page":"21001","DOI":"10.1038\/s41598-020-77970-7","volume":"10","author":"SF Awad","year":"2020","unstructured":"Awad SF, et al. Characterizing the type 2 diabetes mellitus epidemic in Jordan up to 2050. Sci Rep. 2020;10(1):21001.","journal-title":"Sci Rep"},{"issue":"4","key":"11358_CR13","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.jksus.2018.03.009","volume":"31","author":"MAK Shakhatreh","year":"2019","unstructured":"Shakhatreh MAK, et al. Uropathogenic Escherichia coli (UPEC) in jordan: prevalence of urovirulence genes and antibiotic resistance. J King Saud Univ - Sci. 2019;31(4):648\u201352.","journal-title":"J King Saud Univ - Sci"},{"key":"11358_CR14","doi-asserted-by":"publisher","unstructured":"Alkhawaldeh R, et al. The appropriateness of empiric treatment of urinary tract infections in a tertiary teaching hospital in joran: A Cross-Sectional study. Antibiotics (Basel). 2022;11(5). https:\/\/doi.org\/10.3390\/antibiotics11050629.","DOI":"10.3390\/antibiotics11050629"},{"issue":"3","key":"11358_CR15","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268\u201381.","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"11358_CR16","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.jdiacomp.2007.01.004","volume":"22","author":"K Ajlouni","year":"2008","unstructured":"Ajlouni K, et al. An increase in prevalence of diabetes mellitus in Jordan over 10 years. J Diabetes Complicat. 2008;22(5):317\u201324.","journal-title":"J Diabetes Complicat"},{"issue":"3","key":"11358_CR17","doi-asserted-by":"publisher","first-page":"374","DOI":"10.3855\/jidc.17490","volume":"17","author":"RH Alsharedeh","year":"2023","unstructured":"Alsharedeh RH, et al. Characterization of ESKAPE pathogens in urinary tract infections among Jordanian patients. J Infect Dev Ctries. 2023;17(3):374\u201380.","journal-title":"J Infect Dev Ctries"},{"issue":"8","key":"11358_CR18","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/s00345-015-1722-1","volume":"34","author":"Z Tando\u011fdu","year":"2016","unstructured":"Tando\u011fdu Z, et al. Antimicrobial resistance in urosepsis: outcomes from the multinational, multicenter global prevalence of infections in urology (GPIU) study 2003\u20132013. World J Urol. 2016;34(8):1193\u2013200.","journal-title":"World J Urol"},{"key":"11358_CR19","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/1471-2334-6-54","volume":"6","author":"M Bonadio","year":"2006","unstructured":"Bonadio M, et al. The influence of diabetes mellitus on the spectrum of uropathogens and the antimicrobial resistance in elderly adult patients with urinary tract infection. BMC Infect Dis. 2006;6:54.","journal-title":"BMC Infect Dis"},{"issue":"sup1","key":"11358_CR20","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1080\/1120009X.2017.1380395","volume":"29","author":"A Mazzariol","year":"2017","unstructured":"Mazzariol A, Bazaj A, Cornaglia G. Multi-drug-resistant Gram-negative bacteria causing urinary tract infections: a review. J Chemother. 2017;29(sup1):2\u20139.","journal-title":"J Chemother"},{"issue":"1","key":"11358_CR21","first-page":"92","volume":"79","author":"S Shahsavari","year":"2024","unstructured":"Shahsavari S, et al. Effect of diabetes mellitus on the spectrum of uropathogens and the antimicrobial resistance in patients with urinary tract infection. Arch Razi Inst. 2024;79(1):92\u2013101.","journal-title":"Arch Razi Inst"},{"issue":"1","key":"11358_CR22","doi-asserted-by":"publisher","first-page":"214","DOI":"10.4314\/ahs.v21i1.28","volume":"21","author":"E Guclu","year":"2021","unstructured":"Guclu E, et al. Risk factors of multidrug-resistant bacteria in community-acquired urinary tract infections. Afr Health Sci. 2021;21(1):214\u20139.","journal-title":"Afr Health Sci"},{"issue":"1","key":"11358_CR23","doi-asserted-by":"publisher","first-page":"e12897","DOI":"10.1016\/j.heliyon.2023.e12897","volume":"9","author":"MC Shill","year":"2023","unstructured":"Shill MC, et al. Microbial sensitivity of the common pathogens for utis are declining in diabetic patients compared to non-diabetic patients in bangladesh: an institution-based retrospective study. Heliyon. 2023;9(1):e12897.","journal-title":"Heliyon"},{"issue":"10","key":"11358_CR24","doi-asserted-by":"publisher","first-page":"e47707","DOI":"10.1371\/journal.pone.0047707","volume":"7","author":"CF van der Donk","year":"2012","unstructured":"van der Donk CF, et al. Antimicrobial resistance and spread of multi drug resistant Escherichia coli isolates collected from nine urology services in the euregion Meuse-Rhine. PLoS ONE. 2012;7(10):e47707.","journal-title":"PLoS ONE"},{"key":"11358_CR25","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.2147\/IDR.S201849","volume":"12","author":"S Prasada","year":"2019","unstructured":"Prasada S, et al. Changing antibiotic susceptibility pattern in uropathogenic Escherichia coli over a period of 5 years in a tertiary care center. Infect Drug Resist. 2019;12:1439\u201343.","journal-title":"Infect Drug Resist"},{"issue":"4","key":"11358_CR26","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.ijantimicag.2016.12.017","volume":"49","author":"YK Yoon","year":"2017","unstructured":"Yoon YK, et al. Role of piperacillin\/tazobactam as a carbapenem-sparing antibiotic for treatment of acute pyelonephritis due to extended-spectrum \u03b2-lactamase-producing Escherichia coli. Int J Antimicrob Agents. 2017;49(4):410\u20135.","journal-title":"Int J Antimicrob Agents"},{"issue":"34","key":"11358_CR27","doi-asserted-by":"publisher","first-page":"e228","DOI":"10.3346\/jkms.2019.34.e228","volume":"34","author":"YJ Kim","year":"2019","unstructured":"Kim YJ, et al. Change in the annual antibiotic susceptibility of Escherichia coli in Community-Onset urinary tract infection between 2008 and 2017 in a tertiary care hospital in Korea. J Korean Med Sci. 2019;34(34):e228.","journal-title":"J Korean Med Sci"},{"issue":"4","key":"11358_CR28","doi-asserted-by":"publisher","first-page":"403","DOI":"10.33073\/pjm-2019-048","volume":"68","author":"B Kot","year":"2019","unstructured":"Kot B. Antibiotic resistance among uropathogenic Escherichia coli. Pol J Microbiol. 2019;68(4):403\u201315.","journal-title":"Pol J Microbiol"},{"key":"11358_CR29","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1186\/s12879-015-1282-4","volume":"15","author":"O Fasugba","year":"2015","unstructured":"Fasugba O, et al. Ciprofloxacin resistance in community- and hospital-acquired Escherichia coli urinary tract infections: a systematic review and meta-analysis of observational studies. BMC Infect Dis. 2015;15:545.","journal-title":"BMC Infect Dis"},{"issue":"9","key":"11358_CR30","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/S1473-3099(11)70054-8","volume":"11","author":"DJ Morgan","year":"2011","unstructured":"Morgan DJ, et al. Non-prescription antimicrobial use worldwide: a systematic review. Lancet Infect Dis. 2011;11(9):692\u2013701.","journal-title":"Lancet Infect Dis"},{"key":"11358_CR31","doi-asserted-by":"publisher","unstructured":"Van TT, et al. Don\u2019t Get Wound Up: Revised Fluoroquinolone Breakpoints for Enterobacteriaceae and Pseudomonas aeruginosa. J Clin Microbiol. 2019;57(7). https:\/\/doi.org\/10.1128\/JCM.02072-18.","DOI":"10.1128\/JCM.02072-18"},{"issue":"3","key":"11358_CR32","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S1473-3099(10)70027-X","volume":"10","author":"ME Hulscher","year":"2010","unstructured":"Hulscher ME, Grol RP, van der Meer JW. Antibiotic prescribing in hospitals: a social and behavioural scientific approach. Lancet Infect Dis. 2010;10(3):167\u201375.","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"11358_CR33","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.cmi.2022.01.030","volume":"28","author":"A Lawandi","year":"2022","unstructured":"Lawandi A, Yek C, Kadri SS. IDSA guidance and ESCMID guidelines: complementary approaches toward a care standard for MDR Gram-negative infections. Clin Microbiol Infect. 2022;28(4):465\u20139.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"11358_CR34","doi-asserted-by":"publisher","first-page":"e631","DOI":"10.1016\/j.cmi.2015.08.019","volume":"22","author":"M Kresken","year":"2016","unstructured":"Kresken M, et al. Comparative in vitro activity of oral antimicrobial agents against Enterobacteriaceae from patients with community-acquired urinary tract infections in three European countries. Clin Microbiol Infect. 2016;22(1):e631\u20135.","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"11358_CR35","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jhin.2014.07.009","volume":"88","author":"T Inns","year":"2014","unstructured":"Inns T, et al. Service evaluation of selected risk factors for extended-spectrum beta-lactamase < em >Escherichia coli urinary tract infections: a case\u2013control study. Journal of Hospital Infection. 2014;88(2):116\u20139.","journal-title":"Journal of Hospital Infection"},{"issue":"1","key":"11358_CR36","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1136\/jech-2020-216029","volume":"76","author":"RM Carrillo-Larco","year":"2022","unstructured":"Carrillo-Larco RM, et al. Type 2 diabetes mellitus and antibiotic-resistant infections: a systematic review and meta-analysis. J Epidemiol Community Health. 2022;76(1):75\u201384.","journal-title":"J Epidemiol Community Health"},{"issue":"1","key":"11358_CR37","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.pcd.2017.08.003","volume":"12","author":"JEM Vinken","year":"2018","unstructured":"Vinken JEM, et al. Antimicrobial resistance in women with urinary tract infection in primary care: no relation with type 2 diabetes mellitus. Prim Care Diabetes. 2018;12(1):80\u20136.","journal-title":"Prim Care Diabetes"},{"key":"11358_CR38","doi-asserted-by":"publisher","unstructured":"Confederat L-G, et al. Particularities of urinary tract infections in diabetic patients: A concise review. Medicina. 2023;59. https:\/\/doi.org\/10.3390\/medicina59101747.","DOI":"10.3390\/medicina59101747"},{"issue":"3\u20134","key":"11358_CR39","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/j.1574-695X.1999.tb01397.x","volume":"26","author":"SE Geerlings","year":"1999","unstructured":"Geerlings SE, Hoepelman AI. Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol. 1999;26(3\u20134):259\u201365.","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"8","key":"11358_CR40","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.2337\/diacare.25.8.1405","volume":"25","author":"SE Geerlings","year":"2002","unstructured":"Geerlings SE, et al. Adherence of type 1-Fimbriated Escherichia coli to uroepithelial cells: more in diabetic women than in control subjects. Diabetes Care. 2002;25(8):1405\u20139.","journal-title":"Diabetes Care"},{"key":"11358_CR41","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3389\/fphar.2010.00136","volume":"1","author":"S Golbidi","year":"2010","unstructured":"Golbidi S, Laher I. Bladder dysfunction in diabetes mellitus. Front Pharmacol. 2010;1:136.","journal-title":"Front Pharmacol"},{"issue":"8","key":"11358_CR42","doi-asserted-by":"publisher","first-page":"ofaa302","DOI":"10.1093\/ofid\/ofaa302","volume":"7","author":"A Berti","year":"2020","unstructured":"Berti A, et al. Antibiotics and innate immunity: A cooperative effort toward the successful treatment of infections. Open Forum Infect Dis. 2020;7(8):ofaa302.","journal-title":"Open Forum Infect Dis"},{"issue":"5","key":"11358_CR43","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.jsps.2018.02.023","volume":"26","author":"J Tenney","year":"2018","unstructured":"Tenney J, et al. Risk factors for aquiring multidrug-resistant organisms in urinary tract infections: A systematic literature review. Saudi Pharm J. 2018;26(5):678\u201384.","journal-title":"Saudi Pharm J"},{"key":"11358_CR44","doi-asserted-by":"publisher","unstructured":"Al-Tamimi M, et al. Gram-Positive bacterial infections and antibiotics resistance in jordan: current status and future perspective. Jordan Med J. 2022;56(1). https:\/\/doi.org\/10.35516\/jmj.v56i1.219.","DOI":"10.35516\/jmj.v56i1.219"},{"key":"11358_CR45","doi-asserted-by":"publisher","first-page":"p6573215","DOI":"10.1155\/2016\/6573215","volume":"2016","author":"M Sewify","year":"2016","unstructured":"Sewify M, et al. Prevalence of urinary tract infection and antimicrobial susceptibility among diabetic patients with controlled and uncontrolled glycemia in Kuwait. J Diabetes Res. 2016;2016:p6573215.","journal-title":"J Diabetes Res"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11358-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11358-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11358-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T19:47:22Z","timestamp":1757360842000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11358-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,26]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11358"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11358-8","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,26]]},"assertion":[{"value":"18 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008. This study was approved by the Institutional Review Board (IRB) at King Abdullah University Hospital (KAUH) and Jordan University of Science and Technology (JUST) (IRB approval number: 33\/136\/2020). The requirement for informed consent was waived by the IRB due to the nature of the study, according to Policy No.: GM7601.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"945"}}